Actually there are 2 questions first and most important is , how well does Leronlimab perform when all the dust settles in our CD12 trial. Which if good leads to the second question , what will the FDA’s reaction be to positive results. They will either approve or continue with the same stall tactics , such as changing the dosage or whatever other technicality they can find . CyDy management has not ran a mistake free campaign that is without debate . However as I continue to point out our drug has way more upside or benefit than any side effects or downside since there are none and it can be used at any phase and on any patient throughout the covid 19 process. According to what I read off of the FDA guidelines a drug that meets that criteria should be approved . We had the best results for HIV what does the FDA do they change the dosage . Our drug should have been approved by now